default author photo

Thomas Hwang

Harvard University - Brigham and Women's Hospital

SCHOLARLY PAPERS

3

DOWNLOADS

1,428

TOTAL CITATIONS

4

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

Biosimilar Entry and the Pricing of Biologic Drugs

Review of Industrial Organization, 0[10.1007/s11151-026-10056-2]
Number of pages: 40 Posted: 01 Feb 2021 Last Revised: 03 Jun 2026
Luca Maini, Josh Feng, Thomas Hwang and Jacob Klimek
Harvard University - Harvard Medical School, University of Utah - David Eccles School of Business, Harvard University - Brigham and Women's Hospital and University of North Carolina at Chapel Hill
Downloads 616 (109,586)
Citation 1

Abstract:

Loading...

Biosimilars, Drug Pricing, Generic Drugs

2.

Mergers that Matter: The Impact of M&A Activity in Prescription Drug Markets

Number of pages: 64 Posted: 08 Aug 2023 Last Revised: 28 Oct 2025
Josh Feng, Thomas Hwang, Yunjuan Liu and Luca Maini
University of Utah - David Eccles School of Business, Harvard University - Brigham and Women's Hospital, University of North Carolina (UNC) at Chapel Hill - Department of Economics and Harvard University - Harvard Medical School
Downloads 547 (126,105)
Citation 1

Abstract:

Loading...

Mergers and Acquisitions, Drug Pricing, Pharmaceutical Industry, Antitrust, Bargaining

3.

Profiting from Most-Favored Customer Procurement Rules: Evidence from Medicaid

American Economic Journal: Economic Policy, volume 15, issue 2, 2023[10.1257/pol.20200688]
Number of pages: 40 Posted: 20 Mar 2020 Last Revised: 18 Nov 2024
Josh Feng, Thomas Hwang and Luca Maini
University of Utah - David Eccles School of Business, Harvard University - Brigham and Women's Hospital and Harvard University - Harvard Medical School
Downloads 265 (289,513)
Citation 2

Abstract:

Loading...

Medicaid, Pharmaceutical Market, Bargaining, Most-Favored Customer Clauses, Procurement